Dharti Proteins Ltd files unaudited Q2 FY2026 results
The company posted its unaudited standalone financial results for the quarter ended 30 June 2026, approved by the board on 15 July 2026.
What Dharti Proteins Ltd announced
Dharti Proteins Ltd (BSE: 531171) submitted its unaudited standalone financial results for the quarter ended 30 June 2026. The filing was made on 15 July 2026 and the results were approved by the Board of Directors in a meeting held on the same day. The announcement does not contain any specific financial figures such as revenue, profit or earnings per share.
Details of the filing
The filing, uploaded to the BSE portal, is titled “The Un‑audited Standalone Financial Results for the quarter ended June 30, 2026, as approved by Board of Directors in their meeting held on Wednesday, July 15, 2026, has been attached herewith.” It is a standard regulatory submission that informs the market of the company’s quarterly performance before the audited numbers are released. The PDF linked in the filing is expected to contain the detailed statement of profit and loss, balance sheet and cash‑flow items, but those details are not reproduced in the brief announcement.
Key facts at a glance
| Detail | Value |
|---|---|
| Company | Dharti Proteins Ltd |
| BSE ticker | 531171 |
| Filing date | 15 July 2026 (10:17:26 UTC) |
| Period covered | Quarter ended 30 June 2026 |
| Result type | Un‑audited standalone financial results |
| Source | BSE corporate filing (PDF) |
Why this matters for investors
The submission provides investors with an early view of the company’s quarterly performance, albeit without audited assurance. It signals that the board has reviewed the numbers and found them acceptable for preliminary disclosure. While the announcement does not reveal the actual figures, the filing creates a timeline for when audited results are expected, typically within the statutory filing window. Investors can download the attached PDF to examine the detailed numbers, but must treat the data as provisional until the audit is completed.
Conclusion
Dharti Proteins Ltd has complied with regulatory requirements by filing its unaudited Q2 FY2026 results on 15 July 2026, with board approval recorded on the same day. The announcement itself does not disclose financial metrics; interested shareholders should refer to the attached PDF for the full statement. Audited results will follow in the next statutory filing, providing final confirmation of the company’s performance for the quarter.
Frequently asked questions
Source filing: view original